{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:35:20Z","timestamp":1793018120559,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013671","name":"Sun Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13555-026-01949-x","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:21:06Z","timestamp":1791300066000},"page":"5727-5741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Canadian Expert Consensus Recommendations on the Use of Photodynamic Therapy in Actinic Keratosis"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8315-2522","authenticated-orcid":false,"given":"Vimal H.","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alim R.","family":"Devani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Sauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Nigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan V.","family":"Litvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Lynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaggi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1949_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2340\/00015555-2692","volume":"97","author":"R Cerio","year":"2017","unstructured":"Cerio R, Dirschka T, Dr\u00e9no B, et al. Actinic keratosis, a chronic, progressive disease: understanding clinical gaps to optimise patient management. Acta Derm Venereol. 2017;97:997\u20138.","journal-title":"Acta Derm Venereol"},{"key":"1949_CR2","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.jaad.2021.02.082","volume":"85","author":"DB Eisen","year":"2021","unstructured":"Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85:e209\u201333.","journal-title":"J Am Acad Dermatol"},{"key":"1949_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jdv.14092","volume":"31","author":"E Stockfleth","year":"2017","unstructured":"Stockfleth E. The importance of treating the field in actinic keratosis. J Eur Acad Dermatol Venereol. 2017;31:8\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12420","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169:502\u201318.","journal-title":"Br J Dermatol"},{"key":"1949_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.14852","volume":"177","author":"JA Siegel","year":"2017","unstructured":"Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. 2017;177:350\u20138.","journal-title":"Br J Dermatol"},{"key":"1949_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000366525","volume":"46","author":"AC Green","year":"2015","unstructured":"Green AC. Epidemiology of actinic keratoses. Curr Probl Dermatol. 2015;46:1\u20137.","journal-title":"Curr Probl Dermatol"},{"key":"1949_CR7","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1403S1a146S","author":"JR Thamm","year":"2024","unstructured":"Thamm JR, Schuh S, Welzel J. Epidemiology and risk factors of actinic keratosis. What is new for the management for sun-damaged skin. Dermatol Pract Concept. 2024. https:\/\/doi.org\/10.5826\/dpc.1403S1a146S.","journal-title":"Dermatol Pract Concept"},{"key":"1949_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/00015555-3690","volume":"101","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine K, Painchault C, Brignone M. Systematic literature review and network meta-analysis of the efficacy and acceptability of interventions in actinic keratoses. Acta Derm Venereol. 2021;101:1\u20138.","journal-title":"Acta Derm Venereol"},{"key":"1949_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09722-8","author":"T Steeb","year":"2022","unstructured":"Steeb T, Petzold A, Hornung A, Wessely A, Berking C, Heppt MV. Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials. Sci Rep. 2022. https:\/\/doi.org\/10.1038\/s41598-022-09722-8.","journal-title":"Sci Rep"},{"key":"1949_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40257-022-00674-3","volume":"23","author":"L Del Regno","year":"2022","unstructured":"Del Regno L, Catapano S, Di Stefani A, Cappilli S, Peris K. A review of existing therapies for actinic keratosis: current status and future directions. Am J Clin Dermatol. 2022;23:339\u201352.","journal-title":"Am J Clin Dermatol"},{"key":"1949_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11143953","author":"SA Yoo","year":"2022","unstructured":"Yoo SA, Kim YH, Han JH, Bang CH, Park YM, Lee JH. Treatment of actinic keratosis: the best choice through an observational study. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11143953.","journal-title":"J Clin Med"},{"key":"1949_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204736","author":"T Steeb","year":"2021","unstructured":"Steeb T, Wessely A, Petzold A, et al. How to assess the efficacy of interventions for actinic keratosis? A review with a focus on long-term results. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10204736.","journal-title":"J Clin Med"},{"key":"1949_CR13","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/jdv.16017","volume":"33","author":"CA Morton","year":"2019","unstructured":"Morton CA, Szeimies RM, Basset-Seguin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications \u2013 actinic keratoses, Bowen\u2019s disease and basal cell carcinomas. J Eur Acad Dermatol Venereol. 2019;33:2225\u201338.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26390","author":"G Mpourazanis","year":"2022","unstructured":"Mpourazanis G, Konschake W, Vogiatzis R, et al. The role and effectiveness of photodynamic therapy on patients with actinic keratosis: a systematic review and meta-analysis. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.26390.","journal-title":"Cureus"},{"key":"1949_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pdpdt.2018.11.005","volume":"25","author":"XL Mei","year":"2019","unstructured":"Mei XL, Wang L, Zhang R, Zhong S. Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: a meta-analysis of randomized controlled trials. Photodiagnosis Photodyn Ther. 2019;25:23\u20138.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1949_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/CCID.S167498","volume":"12","author":"M Nguyen","year":"2019","unstructured":"Nguyen M, Sandhu SS, Sivamani RK. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis\u2014a review of the literature. Clin Cosmet Investig Dermatol. 2019;12:427\u201335.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1949_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17061050","author":"E Sotiriou","year":"2025","unstructured":"Sotiriou E, Kiritsi D, Chaitidis N, Arabatzis M, Lallas A, Vakirlis E. Daylight photodynamic therapy for actinic keratosis and field cancerization: a narrative review. Cancers. 2025. https:\/\/doi.org\/10.3390\/cancers17061050.","journal-title":"Cancers"},{"key":"1949_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/jdv.16125","volume":"34","author":"I Bernad","year":"2020","unstructured":"Bernad I, Aguado L, N\u00fa\u00f1ez-C\u00f3rdoba JM, Redondo P. Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial. J Eur Acad Dermatol Venereol. 2020;34:1464\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/jdv.15852","volume":"34","author":"YCC Liew","year":"2020","unstructured":"Liew YCC, De Souza NNA, Sultana RG, Oh CC. Photodynamic therapy for the prevention and treatment of actinic keratosis\/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020;34:251\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMoa1811850","volume":"380","author":"MHE Jansen","year":"2019","unstructured":"Jansen MHE, Kessels JPHM, Nelemans PJ, et al. Randomized trial of four treatment approaches for actinic keratosis. N Engl J Med. 2019;380:935\u201346.","journal-title":"N Engl J Med"},{"key":"1949_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jdv.16044","volume":"34","author":"CA Morton","year":"2020","unstructured":"Morton CA, Szeimies RM, Basset-S\u00e9guin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications\u2013field cancerization, photorejuvenation and inflammatory\/infective dermatoses. J Eur Acad Dermatol Venereol. 2020;34:17\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13555-023-00888-1","volume":"13","author":"AS Farberg","year":"2023","unstructured":"Farberg AS, Marson JW, Soleymani T. Advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer: a narrative review. Dermatol Ther (Heidelb). 2023;13:689\u2013716.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1067\/mjd.2003.49","volume":"48","author":"DM Pariser","year":"2003","unstructured":"Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48(2):227\u201332.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1949_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archderm.140.1.41","volume":"140","author":"DJ Piacquadio","year":"2004","unstructured":"Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase\u00a03, multicenter trials. Arch Dermatol. 2004;140(1):41\u201346. https:\/\/doi.org\/10.1001\/archderm.140.1.41.","journal-title":"Arch Dermatol"},{"key":"1949_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bjd.14498","volume":"175","author":"U Reinhold","year":"2016","unstructured":"Reinhold U, Dirschka T, Ostendorf R, et al. A randomized, double-blind, phase\u00a0III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u00ae) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED\u00ae lamp. Br J Dermatol. 2016;175:696\u2013705.","journal-title":"Br J Dermatol"},{"key":"1949_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2133.2010.09873.x","volume":"163","author":"RM Szeimies","year":"2010","unstructured":"Szeimies RM, Radny P, Sebastian M, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase\u00a0III study. Br J Dermatol. 2010;163:386\u201394.","journal-title":"Br J Dermatol"},{"key":"1949_CR27","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase\u00a0III study throughout Europe. J Eur Acad Dermatol Venereol. 2015;29:2342\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1949_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/bjd.13138","volume":"171","author":"DM Rubel","year":"2014","unstructured":"Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol. 2014;171:1164\u201371.","journal-title":"Br J Dermatol"},{"key":"1949_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pdpdt.2017.07.002","volume":"19","author":"JM Ang","year":"2017","unstructured":"Ang JM, Riaz IB, Kamal MU, Paragh G, Zeitouni NC. Photodynamic therapy and pain: a systematic review. Photodiagnosis Photodyn Ther. 2017;19:308\u201344.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1949_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bjd.13547","volume":"173","author":"A Klein","year":"2015","unstructured":"Klein A, Karrer S, Horner C, et al. Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial. Br J Dermatol. 2015;173:192\u2013200.","journal-title":"Br J Dermatol"},{"key":"1949_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102782","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shen S, Wang P, Wang X. Efficacy of photodynamic therapy in actinic cheilitis: a systematic review. Photodiagnosis Photodyn Ther. 2022. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.102782.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"1949_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2133.2008.08610.x","volume":"159","author":"CM Perrett","year":"2008","unstructured":"Perrett CM, Walker SL, O\u2019Donovan P, et al. Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol. 2008;159:198\u2013204.","journal-title":"Br J Dermatol"},{"key":"1949_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2340\/00015555-2612","volume":"97","author":"CV Nissen","year":"2017","unstructured":"Nissen CV, Heerfordt IM, Wiegell SR, Mikkelsen CS, Wulf HC. Pretreatment with 5-fluorouracil cream enhances the efficacy of daylight-mediated photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2017;97:617\u201321.","journal-title":"Acta Derm Venereol"},{"key":"1949_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jamadermatol.2017.0849","volume":"153","author":"TA Petukhova","year":"2017","unstructured":"Petukhova TA, Hassoun LA, Foolad N, Barath M, Sivamani RK. Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: a randomized clinical trial. JAMA Dermatol. 2017;153:637\u201343.","journal-title":"JAMA Dermatol"},{"key":"1949_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/bjd.17096","volume":"180","author":"E Wenande","year":"2019","unstructured":"Wenande E, Phothong W, Bay C, Karmisholt KE, Haedersdal M, Togsverd-Bo K. Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization. Br J Dermatol. 2019;180:756\u201364.","journal-title":"Br J Dermatol"},{"key":"1949_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2022.02.067","volume":"87","author":"TA Bullock","year":"2022","unstructured":"Bullock TA, Negrey J, Hu B, Warren CB, Hasan T, Maytin EV. Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin\u00a0D pretreatment: an interventional cohort-controlled trial. J Am Acad Dermatol. 2022;87:80\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1949_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103703","author":"C Pihl","year":"2023","unstructured":"Pihl C, Lerche CM, Andersen F, Bjerring P, Haedersdal M. Improving the efficacy of photodynamic therapy for actinic keratosis: a comprehensive review of pharmacological pretreatment strategies. Photodiagnosis Photodyn Ther. 2023. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103703.","journal-title":"Photodiagnosis Photodyn Ther"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01949-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01949-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:05:54Z","timestamp":1793016354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01949-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01949-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Vimal H. Prajapati:\u00a0Advisor, consultant, and\/or speaker for: AbbVie, Actelion, Amgen, Apogee Therapeutics, Aralez, Arcutis, Aspen, Bausch Health, BioJAMP\/JAMP Pharma, BioScript Solutions, Boehringer Ingelheim, Bristol Myers Squibb, Canadian Psoriasis Network, Celgene, Celltrion, Cipher, CorEvitas, Eczema Society of Canada, Galderma, GlaxoSmithKline, Homeocan, Incyte, J&J Innovative Medicine, Janssen, Johnson & Johnson, Kenvue, Knight Therapeutics, LEO Pharma, Lilly, Medexus, Nia Health, Novartis, Organon, Paladin, Pediapharm, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, Tribute, and UCB; Investigator\/researcher for: AbbVie, AnaptysBio, Apogee Therapeutics, Arcutis, Arena, Asana, Bausch Health, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert, CorEvitas, Dermavant, Dermira, Galderma, Incyte, J&J Innovative Medicine, Janssen, LEO Pharma, Lilly, Nektar Therapeutics, Nimbus Lakshmi, Novartis, Pfizer, Q32 Bio, RAPT Therapeutics, Regeneron, Reistone, Roche, Sanofi Genzyme, Sun Pharma, Takeda, UCB, and Vyne Therapeutics; Received grants from: AbbVie, Bausch Health, Janssen, LEO Pharma, Novartis, and Sanofi Genzyme. Vincent Richer:\u00a0Advisor, consultant, and\/or speaker for: AbbVie\/Allergan, Galderma, Inmagene, Ipsen, Kenvue, L\u2019Or\u00e9al, LEO Pharma, and Merz; Investigator\/researcher for: AbbVie\/Allergan, Galderma, Inmagene, Ipsen, Kenvue, L\u2019Or\u00e9al, LEO Pharma, and Merz. Megan Sander:\u00a0Advisor, consultant, and\/or speaker for: AbbVie, Celgene, Amgen, Janssen, L\u2019Or\u00e9al, Vichy, Novartis, Sanofi Genzyme, Johnson & Johnson, UCB, Aralez, LEO Pharma, Galderma, Eli Lilly, Miravo Healthcare, Sun Pharma, and Bausch Health. Alim R. Devani:\u00a0Advisor, consultant, and\/or speaker for: AbbVie, Actelion, Amgen, Apogee Therapeutics, Aralez, Arcutis, Bausch Health, BioJAMP\/JAMP Pharma, BioScript Solutions, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Cipher, Galderma, GlaxoSmithKline, Homeocan, Incyte, J&J Innovative Medicine, Janssen, Johnson & Johnson, Kenvue, LEO Pharma, Lilly, Medexus, Novartis, Organon, Paladin, Pediapharm, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, Tribute, and UCB; Investigator\/researcher for the same organizations. Sonya Abdulla:\u00a0Advisor, consultant, and\/or speaker for: Bausch Health, Galderma, L\u2019Or\u00e9al, and Sun Pharma; Investigator\/researcher for: Bausch Health, L\u2019Or\u00e9al, and Sun Pharma. Maxwell Sauder:\u00a0Advisor, consultant, and\/or speaker for: Bausch Health, Bristol Myers Squibb, Galderma, Merck, Regeneron, and Sun Pharma. Simon Nigen:\u00a0Advisor, consultant, and\/or speaker for: 3M, AbbVie, Alumis, Amgen, Anacord, Arcutis, Bausch Health, Bioderma, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Dormer, DS Biopharma, Eli Lilly, Eisai, Galderma, Genzyme, GlaxoSmithKline, Incyte, JAMP, Janssen, Kymab, La Roche-Posay, LEO Pharma, Merck, Novartis, Nuvo-Aralez, Organon, Pediapharm, Pfizer, Regeneron, Reistone, Roche, Sanofi, Sun Pharma, Tolmar, and UCB; Investigator\/researcher for the same organizations. Ivan V. Litvinov:\u00a0Advisor, consultant, and\/or speaker for: Janssen, Bausch Health, Galderma, Novartis, Amgen, Sandoz, Pfizer, Sun Pharmaceutical Industries, LEO Pharma, Sanofi Regeneron, Therakos, Eli Lilly, Kyowa Kirin, Johnson & Johnson, Merck, Bristol Myers Squibb, UCB, and Actelion. Charles W. Lynde:\u00a0Advisor, consultant, and\/or speaker for: AbbVie, Acelyrin, Akros, Altius, Amgen, Apogee, Aralez, Arcutis, Avillion, Bausch Health, Bayer, Bioderma, BioJAMP, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celldex, Celltrion, CeraVe, Cipher, Concert, Dermavant, Dermira, Devonian, DICE, Eli Lilly, Endo, Evelo, Fresenius Kabi, Galderma, GSK, Incyte, Innovaderm, Intega Skin, Janssen, Kyowa Kirin, La Roche-Posay, LEO Pharma, L\u2019Or\u00e9al, MC2, Medexus, MedX, Merck, MoonLake, Naos, Nektar, Nimbus, Novartis, Organon, Oruka, P&G, Paladin, Pediapharm, Pfizer, Regeneron, Roche, Sandoz, Sanofi Genzyme, Searchlight Pharma, Sentrex, SkinCeuticals, Sun Pharma, Takeda, UCB, Viatris, Volo Health, and Vyne; Investigator\/researcher for the same organizations. Jaggi Rao:\u00a0None to declare related to this work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved a modified Delphi consensus process in which healthcare professionals provided expert opinions regarding the use of photodynamic therapy in actinic keratosis. It did not involve patients, clinical interventions, identifiable personal information, patient-level data, or human biological material. Formal institutional ethics review was not obtained for this consensus activity. Patients were not involved in the design, conduct, reporting, or dissemination planning of this modified Delphi consensus study.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}